FEN1 and cancer: Additionally, small-molecule FEN1 inhibitors and small-interfering RNAs of FEN1 selectively killed human cell lines deficient in BRCA1 and BRCA2, confirming the sensitivity of these cancers to FEN1 deficiency [157].